Literature DB >> 14734690

Smoking reduction and tobacco-related cancers: the more things change, the more they stay the same.

Scott J Leischow, Mirjana V Djordjevic.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734690     DOI: 10.1093/jnci/djh030

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  β-Cryptoxanthin supplementation prevents cigarette smoke-induced lung inflammation, oxidative damage, and squamous metaplasia in ferrets.

Authors:  Chun Liu; Roderick T Bronson; Robert M Russell; Xiang-Dong Wang
Journal:  Cancer Prev Res (Phila)       Date:  2011-03-18

Review 2.  Lysyl oxidase, a critical intra- and extra-cellular target in the lung for cigarette smoke pathogenesis.

Authors:  Wande Li; Jing Zhou; Lijun Chen; Zhijun Luo; Yinzhi Zhao
Journal:  Int J Environ Res Public Health       Date:  2011-01-19       Impact factor: 3.390

3.  Smoking reduction interventions for smoking cessation.

Authors:  Nicola Lindson; Elias Klemperer; Bosun Hong; José M Ordóñez-Mena; Paul Aveyard
Journal:  Cochrane Database Syst Rev       Date:  2019-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.